Literature DB >> 32444987

Fluoroless Endourological Surgery for Stone Disease: a Review of the Literature-Tips and Tricks.

E Emiliani1, A Kanashiro2, T Chi3, D A Pérez-Fentes4, B O Manzo5, O Angerri2, B K Somani6.   

Abstract

PURPOSE OF REVIEW: Urologists are at significant risk due to radiation exposure (RE) from endourological procedures for stone disease. Many techniques described have shown a reduction of RE. The purpose of this article is to review available protocols to decrease RE during such procedures and provide tips and tricks for their implementation. RECENT
FINDINGS: Several low-radiation and radiation-free protocols for percutaneous nephrolithotomy and flexible ureteroscopy have been described as an attempt to reduce RE during surgery. Beginning with specific checklists to ensure adequate C-arm usage, fluoroless procedures are based on endoscopic assessment, tactile guidance, and use of ultrasound to avoid fluoroscopy. A specific preoperative checklist and low radiation or complete fluoroless radiation endourological procedures have shown to be effective, feasible, and safe. It is recommended for urologists to be aware of the risks of RE and apply the "ALARA" (As Low As Reasonably Achievable) protocols.

Entities:  

Keywords:  Endourology; Flexible ureteroscopy; Fluoroless; PCNL; Radiation; Urolithiasis

Year:  2020        PMID: 32444987     DOI: 10.1007/s11934-020-00979-y

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  2 in total

1.  Can operator-controlled imaging reduce fluoroscopy time during flexible ureterorenoscopy?

Authors:  Michaël M E L Henderickx; Tim Brits; Natalia S Zabegalina; Joyce Baard; Mansour Ballout; Harrie P Beerlage; Stefan De Wachter; Guido M Kamphuis
Journal:  Cent European J Urol       Date:  2022-01-29

Review 2.  ALARA in Urology: Steps to Minimise Radiation Exposure During All Parts of the Endourological Journey.

Authors:  Radhika Bhanot; Zeeshan B M Hameed; Milap Shah; Patrick Juliebø-Jones; Andreas Skolarikos; Bhaskar Somani
Journal:  Curr Urol Rep       Date:  2022-08-13       Impact factor: 2.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.